CoChat
Sign Up
Cited by 13

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis

Sharma, Satyam, Bhattacharya, Sankha, Joshi, Kajal, Singh, Sanjiv·2023·Journal of Cancer Research and Clinical Oncology
DOI 10.1007/s00432-023-05331-8
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00432-023-05331-8

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 115

  1. Abdel-Salam M, Omran B, Whitehead K, Baek K-H (2020) Superior properties and biomedical applications of microorganism-derived fluorescent quantum dots. Molecules 25(19):4486 · DOI
  2. Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliver Rev 63(3):170–183 · DOI
  3. Aibani N, Rai R, Patel P, Cuddihy G, Wasan EK (2021) Chitosan nanoparticles at the biological interface: implications for drug delivery. Pharmaceutics 13(10):1686 · DOI · Paper page
  4. Alharbi NS, Alsubhi NS (2022) Green synthesis and anticancer activity of silver nanoparticles prepared using fruit extract of Azadirachta indica. J Radiat Res Appl Sci 15(3):335–345
  5. Al-Joufi FA, Setia A, Salem-Bekhit MM, Sahu RK, Alqahtani FY, Widyowati R, Aleanizy FS (2022) Molecular pathogenesis of colorectal cancer with an emphasis on recent advances in biomarkers, as well as nanotechnology-based diagnostic and therapeutic approaches. Nanomaterials 12(1):169 · DOI
  6. Alshammari A, Alharbi M, Albekairi NA, Albekairi TH, Alharbi OO, Yeapuri P, Singh S (2022) Protective effect of CP690550 in MPTP-induced Parkinson’s like behavioural. Biochem Histol Alterat Mice Neurotoxicity Res 40(2):564–572 · DOI
  7. Alzahrani SM, Al Doghaither HA, Al-Ghafari AB (2021) General insight into cancer: an overview of colorectal cancer. Mol Clin Oncol 15(6):1–8 · DOI
  8. Anselmo AC, Mitragotri S (2019) Nanoparticles in the clinic: an update. Bioeng Transl Med 4(3):e10143 · DOI · Paper page
  9. Anuse SS, Sumathi V, Uma C, Sangeetha D, Sivagurunathan P, Kumar DJM (2022) Greener synthesis and characterization of the selenium nanoparticles from acacia catechu. Uttar Pradesh J Zool 43(24):58–71. https://doi.org/10.56557/upjoz/2022/v43i243286 · DOI
  10. Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF (2019) An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol 71(8):1185–1198 · DOI
  11. Bansal SA, Kumar V, Karimi J, Singh AP, Kumar S (2020) Role of gold nanoparticles in advanced biomedical applications. Nanoscale Adv 2(9):3764–3787 · DOI
  12. Barabadi H, Vahidi H, DamavandiKamali K, Rashedi M, Hosseini O, GolnaraghiGhomi AR, Saravanan M (2020a) Emerging theranostic silver nanomaterials to combat colorectal cancer: a systematic review. J Cluster Sci 31(2):311–321 · DOI
  13. Barabadi H, Vahidi H, Rashedi M, Mahjoub MA, Nanda A, Saravanan MJNJ (2020b) Recent advances in biological mediated cancer research using silver nanoparticles as a promising strategy for hepatic cancer therapeutics: a systematic review. Nanomed J 7(4):251–262
  14. Barani M, Bilal M, Rahdar A, Arshad R, Kumar A, Hamishekar H, Kyzas GZ (2021) Nanodiagnosis and nanotreatment of colorectal cancer: an overview. J Nanopart Res 23(1):18 · DOI
  15. Barkat A, Beg S, Panda SK, Alharbi KS, Rahman M, Ahmed FJ (2021) Functionalized mesoporous silica nanoparticles in anticancer therapeutics. In: Seminars in Cancer Biology, Elsevier, pp 365–375 · DOI
  16. Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen Y-J, Ciombor KK, Cohen S, Cooper HS, Deming D, Farkas L (2021) Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 19(3):329–359 · DOI
  17. Berry S, Giraldo N, Nguyen P, Green B, Xu H, Ogurtsova A, Soni A, Succaria F, Wang D, Roberts C (2019) Correction to: 33rd annual meeting and pre-conference programs of the society for immunotherapy of cancer (SITC 2018). J Immunother Cancer 7:1–11 · DOI
  18. Bhattacharya S, Prajapati BG, Singh S (2023) A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy. Crit Rev Oncol Hematol 185:103961 · DOI
  19. Biranje A, Azmi N, Tiwari A, Chaskar A (2021) Quantum dots based fluorescent probe for the selective detection of heavy metal ions. J Fluoresc 31(5):1241–1250 · DOI
  20. Blakeley M, Sharma PK, Kaper HJ, Bostanci N, Crouzier T (2022) Lectin-functionalized polyethylene glycol for relief of mucosal dryness. Adv Healthcare Mater 11(2):2101719 · DOI
  21. Bouché M, Hsu JC, Dong YC, Kim J, Taing K, Cormode DP (2019) Recent advances in molecular imaging with gold nanoparticles. Bioconjug Chem 31(2):303–314 · DOI
  22. Brar B, Ranjan K, Palria A, Kumar R, Ghosh M, Sihag S, Minakshi P (2021) Nanotechnology in colorectal cancer for precision diagnosis and therapy. Front Nanotechnol 3:699266 · DOI
  23. Cabeza L, Perazzoli G, Mesas C, Jiménez-Luna C, Prados J, Rama AR, Melguizo C (2020) Nanoparticles in colorectal cancer therapy: latest in vivo assays, clinical trials, and patents. AAPS PharmSciTech 21:1–15 · DOI
  24. Carbary-Ganz JL, Welge WA, Barton JK, Utzinger U (2015) In vivo molecular imaging of colorectal cancer using quantum dots targeted to vascular endothelial growth factor receptor 2 and optical coherence tomography/laser-induced fluorescence dual-modality imaging. J Biomed Opt 20(9):096015–096015 · DOI
  25. Chen C, Zhou Y, Chen C, Zhu S, Yan X (2022) Quantification of available ligand density on the surface of targeted liposomal nanomedicines at the single-particle level. ACS Nano 16(4):6886–6897 · DOI
  26. Choudhary A, Singh S, Ravichandiran V (2022) Toxicity, preparation methods and applications of silver nanoparticles: an update. Toxicol Mech Methods 32(9):650–661 · DOI
  27. Cruz E, Kayser V (2019) Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy. Biologics 33–51 · DOI
  28. D’Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G (2020) New CXCR4 antagonist peptide R (Pep R) improves standard therapy in colorectal cancer. Cancers 12(7):1952 · DOI
  29. Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A (2022) Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology. ACS Nano 16(7):9994–10041 · DOI · Paper page
  30. Elahi N, Rizwan M (2021) Progress and prospects of magnetic iron oxide nanoparticles in biomedical applications: a review. Artif Organs 45(11):1272–1299 · DOI
  31. Elmowafy M, Al-Sanea MM (2021) Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharm J 29(9):999–1012 · DOI
  32. Falz R, Bischoff C, Thieme R, Lässing J, Mehdorn M, Stelzner S, Busse M, Gockel I (2022) Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol 148(9):2187–2213 · DOI · Paper page
  33. Fitzgerald RC, Antoniou AC, Fruk L, Rosenfeld N (2022) The future of early cancer detection. Nat Med 28(4):666–677 · DOI
  34. Galgano SJ, Calderone CE, McDonald AM, Nix JW, de Shazo M, Yang ES, McConathy JE, Rais-Bahrami S (2019) Patient demographics and referral patterns for [F-18] fluciclovine-Pet imaging at a tertiary academic medical center. J Am College Radiol 16(3):315–320 · DOI
  35. Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, Diaz LA Jr (2019) Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol 16(6):361–375 · DOI · Paper page
  36. Garg U, Chauhan S, Nagaich U, Jain N (2019) Current advances in chitosan nanoparticles based drug delivery and targeting. Adv Pharm Bull 9(2):195 · DOI · Paper page
  37. Gockel I, Hochhaus A, Höffken K (2020) Paul Ehrlichs „magic bullets“ und die Präzisionsonkologie. Onkologe 26(8):677–678 · DOI
  38. Gunaydin G, Gedik ME, Ayan S (2021) Photodynamic therapy—current limitations and novel approaches. Front Chem 9:691697 · DOI
  39. Habeeb Rahuman HB, Dhandapani R, Narayanan S, Palanivel V, Paramasivam R, Subbarayalu R, Thangavelu S, Muthupandian S (2022) Medicinal plants mediated the green synthesis of silver nanoparticles and their biomedical applications. IET Nanobiotechnol 16(4):115–144 · DOI
  40. Han S, Chen C, Chen C, Wu L, Wu X, Lu C, Zhang X, Chao P, Lv X, Jia Z, Hou J (2023) Coupling annealed silver nanoparticles with a porous silicon Bragg mirror SERS substrate and machine learning for rapid non-invasive disease diagnosis. Anal Chim Acta 1254:341116 · DOI
  41. Hani U, Honnavalli YK, Begum MY, Yasmin S, Osmani RAM, Ansari MY (2021) Colorectal cancer: a comprehensive review based on the novel drug delivery systems approach and its management. J Drug Deliver Sci Technol 63:102532 · DOI
  42. He J-S, Liu S-J, Zhang Y-R, Chu X-D, Lin Z-B, Zhao Z, Qiu S-H, Guo Y-G, Ding H, Pan Y-L (2021) The application of and strategy for gold nanoparticles in cancer immunotherapy. Front Pharmacol 12:687399 · DOI
  43. Herdiana Y, Wathoni N, Shamsuddin S, Joni IM, Muchtaridi M (2021) Chitosan-based nanoparticles of targeted drug delivery system in breast cancer treatment. Polymers 13(11):1717 · DOI · Paper page
  44. Hernández-Hernández AA, Aguirre-Álvarez G, Cariño-Cortés R, Mendoza-Huizar LH, Jiménez-Alvarado R (2020) Iron oxide nanoparticles: synthesis, functionalization, and applications in diagnosis and treatment of cancer. Chem Pap 74(11):3809–3824 · DOI
  45. Hershberger KK, Gauger AJ, Bronstein LM (2021) Utilizing stimuli responsive linkages to engineer and enhance polymer nanoparticle-based drug delivery platforms. ACS Appl Bio Mater 4(6):4720–4736 · DOI
  46. Hoppenz P, Els-Heindl S, Beck-Sickinger AG (2020) Peptide-drug conjugates and their targets in advanced cancer therapies. Front Chem 8:571 · DOI
  47. Huang R, Li J, Kebebe D, Wu Y, Zhang B, Liu Z (2018) Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment. Drug Delivery 25(1):757–765 · DOI
  48. Jarockyte G, Karabanovas V, Rotomskis R, Mobasheri A (2020) Multiplexed nanobiosensors: current trends in early diagnostics. Sensors 20(23):6890 · DOI
  49. Jhaveri J, Raichura Z, Khan T, Momin M, Omri A (2021) Chitosan nanoparticles-insight into properties, functionalization and applications in drug delivery and theranostics. Molecules 26(2):272 · DOI
  50. Kara G, Calin GA, Ozpolat B (2022) RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliver Rev 182:114113 · DOI
  51. Kaushal D, Gupta S, Pathak YV (2022) Delivery of siRNA to macrophages: challenges and opportunities. Macrophage targeted delivery systems: basic concepts and therapeutic applications, pp 469–487 · DOI
  52. Kenchegowda M, Rahamathulla M, Hani U, Begum MY, Guruswamy S, Osmani RAM, Gowrav MP, Alshehri S, Ghoneim MM, Alshlowi A (2021) Smart nanocarriers as an emerging platform for cancer therapy: a review. Molecules 27(1):146 · DOI
  53. Khan AA (2021) Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence? J Cancer Res Clin Oncol 147(8):2199–2207 · DOI
  54. Krzysztof S, Gorzkiewicz M, Klajnert-Maculewicz BJMP (2019) Gold nanoparticles in cancer treatment. Mol Pharm 16:1–23 · DOI
  55. Kumar A, Ali A, Kapardar RK, Dar GM, Nimisha A, Sharma AK, Verma R, Sattar RSA, Ahmad E, Mahajan B, Saluja SS (2023) Implication of gut microbes and its metabolites in colorectal cancer. J Cancer Res Clin Oncol 149(1):441–465 · DOI
  56. Li Y, Duo Y, Bao S, He L, Ling K, Luo J, Zhang Y, Huang H, Zhang H, Yu X (2017) EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer. Int J Nanomed 12:6239–6257 · DOI
  57. Li T, Shi S, Goel S, Shen X, Xie X, Chen Z, Zhang H, Li S, Qin X, Yang H (2019a) Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer. Acta Biomater 89:1–13 · DOI
  58. Li T, Shi S, Goel S, Shen X, Xie X, Chen Z, Zhang H, Li S, Qin X, Yang H (2019b) Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer. Acta Biomater 89:1–13 · DOI
  59. Liang Z, Khawar MB, Liang J, Sun H (2021) Bio-conjugated quantum dots for cancer research: detection and imaging. Front Oncol 11:749970 · DOI
  60. Liu D, Zhang Q, Wang J, Fan L, Zhu W, Cai D (2019) Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer. Pharmazie 74(2):83–90
  61. Løes IM, Immervoll H, Sorbye H, Angelsen JH, Horn A, Knappskog S, Lønning PE (2016) Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases. Int J Cancer 139(3):647–656 · DOI
  62. Makvandi P, Zarepour A, Zheng X, Agarwal T, Ghomi M, Sartorius R, Zare EN, Zarrabi A, Wu A, Maiti TK (2021) Non-spherical nanostructures in nanomedicine: from noble metal nanorods to transition metal dichalcogenide nanosheets. Appl Mater Today 24:101107 · DOI
  63. Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al Moustafa A-E (2020) Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements. Int J Mol Sci 22(1):130 · DOI
  64. Manthalkar L, Ajazuddin, Bhattacharya S (2022) Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs. Discover Oncol 13(1):142 · DOI
  65. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discovery 20(2):101–124 · DOI · Paper page
  66. Modest D, Pant S, Sartore-Bianchi A (2019) Treatment sequencing in metastatic colorectal cancer. Eur J Cancer 109:70–83 · DOI
  67. Moularas C, Georgiou Y, Adamska K, Deligiannakis Y (2019) Thermoplasmonic heat generation efficiency by nonmonodisperse core-shell Ag0@ SiO2 nanoparticle ensemble. J Phys Chem C 123(36):22499–22510 · DOI
  68. Mukherjee A, Paul M, Mukherjee S (2019) Recent progress in the theranostics application of nanomedicine in lung cancer. Cancers 11(5):597 · DOI
  69. Niculescu A-G, Grumezescu AM (2021) Photodynamic therapy—an up-to-date review. Appl Sci 11(8):3626 · DOI
  70. Noe O, Filipiak L, Royfman R, Campbell A, Lin L, Hamouda D, Stanbery L, Nemunaitis J (2021) Adenomatous polyposis coli in cancer and therapeutic implications. Oncol Rev 15(1):534. https://doi.org/10.4081/oncol.2021.534 · DOI
  71. Ou Y-C, Wen X, Bardhan R (2020) Cancer immunoimaging with smart nanoparticles. Trends Biotechnol 38(4):388–403 · DOI
  72. Panzarini E, Mariano S, Carata E, Mura F, Rossi M, Dini L (2018) Intracellular transport of silver and gold nanoparticles and biological responses: an update. Int J Mol Sci 19(5):1305 · DOI
  73. Raikwar S, Jain A, Saraf S, Bidla PD, Panda PK, Tiwari A, Verma A, Jain SK (2022) Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape. Expert Opin Drug Deliv 19(3):247–268 · DOI
  74. Riadi Y, Afzal O, Geesi MH, Almalki WH, Singh T (2023) Baicalin-loaded lipid-polymer hybrid nanoparticles inhibiting the proliferation of human colon cancer: pharmacokinetics and in vivo evaluation. Polymers 15(3):598 · DOI
  75. Rimu SH, Rahman MM (2022) Insight of chitosan-based nanocomposite for removal of hexavalent chromium from wastewater-a review. Int J Environ Anal Chem 102(18):6801–6818 · DOI
  76. Roy A, Narayan G (2019) Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion. J Cancer Res Clin Oncol 145(12):2901–2910 · DOI
  77. Rudzinski WE, Palacios A, Ahmed A, Lane MA, Aminabhavi TMJ (2016) Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles. Carbohydrate Polym 147:323–332 · DOI
  78. Sanoff HK, Moon DH, Moore DT, Boles J, Bui C, Blackstock W, O’Neil BH, Subramaniam S, McRee AJ, Carlson C (2019) Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer. Nanomedicine 18:189–195 · DOI · Paper page
  79. Schatoff EM, Leach BI, Dow LE (2017) Wnt signaling and colorectal cancer. Current Colorectal Cancer Reports 13(2):101–110 · DOI
  80. Shah D, Ajazuddin, Bhattacharya S (2023) Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents. J Cancer Res Clin Oncol 149(1):367–391 · DOI
  81. Sheikh A, Md S, Alhakamy NA, Kesharwani P (2022) Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics. Int J Pharm 620:121751 · DOI
  82. Shergill A, Liao C-Y, Kindler HL, Polite BN, Catenacci DVT (2022) A phase 1b/2 study of VS-6766 in combination cetuximab in patients (pts) with advanced KRAS mt colorectal cancer (CRC). Am Soc Clin Oncol TPS219-TPS219 · DOI
  83. Siddique S, Chow JC (2020) Application of nanomaterials in biomedical imaging and cancer therapy. Nanomaterials 10(9):1700 · DOI
  84. Siddique S, Chow JC (2022) Recent advances in functionalized nanoparticles in cancer theranostics. Nanomaterials 12(16):2826 · DOI
  85. Silva CO, Pinho JO, Lopes JM, Almeida AJ, Gaspar MM, Reis C (2019) Current trends in cancer nanotheranostics: metallic, polymeric, and lipid-based systems. Pharmaceutics 11(1):22 · DOI
  86. Singh R, Kumar S (2022) Cancer targeting and diagnosis: recent trends with carbon nanotubes. Nanomaterials 12(13):2283 · DOI
  87. Singh N, Handa M, Singh V, Kesharwani P, Shukla R (2022) Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 30(10):1017–1033
  88. Sivadasan D, Sultan MH, Madkhali O, Almoshari Y, Thangavel N (2021) Polymeric lipid hybrid nanoparticles (Plns) as emerging drug delivery platform—a comprehensive review of their properties, preparation methods, and therapeutic applications. Pharmaceutics 13(8):1291 · DOI
  89. Skyrud KD, Myklebust TÅ, Bray F, Eriksen MT, De Lange T, Larsen IK, Møller BJCE (2017) Biomarkers, prevention, how many deaths from colorectal cancer can be prevented by 2030? A scenario-based quantification of risk factor modification, screening, and treatment in Norway. Colorectal Cancer Prevent 26(9):1420–1426
  90. Su Z, Dong S, Zhao S-C, Liu K, Tan Y, Jiang X, Assaraf YG, Qin B, Chen Z-S, Zou C (2021) Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updates 58:100777 · DOI
  91. Subramaniam B, Siddik ZH, Nagoor NH (2020) Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J Nanopart Res 22:1–29 · DOI
  92. Sukocheva OA, Liu J, Neganova ME, Beeraka NM, Aleksandrova YR, Manogaran P, Grigorevskikh EM, Chubarev VN, Fan R (2022) Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers. Seminars in Cancer Biology, Elsevier · DOI
  93. Sundaram P, Abrahamse H (2020) Effective photodynamic therapy for colon cancer cells using chlorin e6 coated hyaluronic acid-based carbon nanotubes. Int J Mol Sci 21(13):4745 · DOI
  94. Tahover E, Bar-Shalom R, Sapir E, Pfeffer R, Nemirovsky I, Turner Y, Gips M, Ohana P, Corn BW, Wang AZ (2018) Chemo-radiotherapy of oligometastases of colorectal cancer with pegylated liposomal mitomycin-C prodrug (promitil): mechanistic basis and preliminary clinical experience. Front Oncol 8:544 · DOI
  95. Tang S-Y, Wei H, Yu C-Y (2021) Peptide-functionalized delivery vehicles for enhanced cancer therapy. Int J Pharm 593:120141 · DOI
  96. Tewabe A, Abate A, Tamrie M, Seyfu A, Abdela Siraj E (2021) Targeted drug delivery—from magic bullet to nanomedicine: principles, challenges, and future perspectives. J Multidisciplin Healthcare 14:1711–1724 · DOI
  97. Tian Q, Liu Y, Zhang Y, Song Z, Yang J, Zhang J, Guo T, Gao W, Dai F, He C (2018) THBS2 is a biomarker for AJCC stages and a strong prognostic indicator in colorectal cancer. J Buon 23(5):1331–1336
  98. Tougeron D, Mouillet G, Trouilloud I, Lecomte T, Coriat R, Aparicio T, Des Guetz G, Lécaille C, Artru P, Sickersen G (2016) Efficacy of adjuvant chemotherapy in colon cancer with microsatellite instability: a large multicenter AGEO study. J Natl Cancer Inst 108(7):djv438 · DOI
  99. Townsend MH, Anderson MD, Weagel EG, Velazquez EJ, Weber KS, Robison RA, O’Neill KL (2017) Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane. Onco Targets Ther 10:1921 · DOI
  100. Trovato V, Teblum E, Kostikov Y, Pedrana A, Re V, Nessim GD, Rosace G (2021) Electrically conductive cotton fabric coatings developed by silica sol-gel precursors doped with surfactant-aided dispersion of vertically aligned carbon nanotubes fillers in organic solvent-free aqueous solution. J Colloid Interface Sci 586:120–134 · DOI
  101. M.C. Turner, Z.J. Andersen, A. Baccarelli, W.R. Diver, S.M. Gapstur, C.A. Pope III, D. Prada, J. Samet, G. Thurston, A.J.C.a.c.j.f.c. Cohen, Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations, 70(6) (2020) 460–479. · DOI
  102. Varanko A, Saha S, Chilkoti A (2020) Recent trends in protein and peptide-based biomaterials for advanced drug delivery. Adv Drug Deliv Rev 156:133–187 · DOI
  103. Vilos C, Morales FA, Solar PA, Herrera NS, Gonzalez-Nilo FD, Aguayo DA, Mendoza HL, Comer J, Bravo ML, Gonzalez PAJB (2013) Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials 34(16):4098–4108 · DOI
  104. Wagner AM, Knipe JM, Orive G, Peppas NA (2019) Quantum dots in biomedical applications. Acta Biomater 94:44–63 · DOI
  105. Wang K, Shen R, Meng T, Hu F, Yuan H (2022) Nano-drug delivery systems based on different targeting mechanisms in the targeted therapy of colorectal cancer. Molecules 27(9):2981 · DOI
  106. Wang Y, Zhai W, Cheng S, Li J, Zhang H (2023) Surface-functionalized design of blood-contacting biomaterials for preventing coagulation and promoting hemostasis. Friction 11(8):1371–1394 · DOI
  107. Weiser MR (2018) AJCC 8th edition: colorectal cancer. Ann Surg Oncol 25(6):1454–1455 · DOI · Paper page
  108. Worm DJ, Els-Heindl S, Beck-Sickinger AG (2020) Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates. Pept Sci 112(3):e24171 · DOI
  109. Wu S, Li Y, Ding W, Xu L, Ma Y, Zhang L (2020) Recent advances of persistent luminescence nanoparticles in bioapplications. Nano-Micro Letters 12:1–26 · DOI
  110. Xie W, Guo Z, Gao F, Gao Q, Wang D, Liaw B-S, Cai Q, Sun X, Wang X, Zhao L (2018) Shape-, size-and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics. Theranostics 8(12):3284 · DOI
  111. Yang C, Merlin D (2020) Lipid-based drug delivery nanoplatforms for colorectal cancer therapy. Nanomaterials 10(7):1424 · DOI
  112. Yasun E, Gandhi S, Choudhury S, Mohammadinejad R, Benyettou F, Gozubenli N, Arami H (2020) Hollow micro and nanostructures for therapeutic and imaging applications. J Drug Delivery Sci Technol 60:102094 · DOI
  113. Zanoni DK, Stambuk HE, Madajewski B, Montero PH, Matsuura D, Busam KJ, Ma K, Turker MZ, Sequeira S, Gonen M (2021) Use of ultrasmall core-shell fluorescent silica nanoparticles for image-guided sentinel lymph node biopsy in head and neck melanoma: a nonrandomized clinical trial. JAMA Netw Open 4(3):e211936–e211936 · DOI
  114. Zhang S, Chai X, Hou G, Zhao F, Meng Q (2002) Platycodon grandiflorum (Jacq.) A. DC.: A review of phytochemistry, pharmacology, toxicology and traditional use. Phytomedicine 154422 · DOI
  115. Zhou L, Liu Y, Sun H, Li H, Zhang Z, Hao P (2022) Usefulness of enzyme-free and enzyme-resistant detection of complement component 5 to evaluate acute myocardial infarction. Sens Actuat B Chem 369:132315 · DOI

Cited by

Sorted by citations

See all 13

Metadata

Authors
Sharma, S., Bhattacharya, S., Joshi, K., & Singh, S.
ORCID
Bhattacharya, Sankha
Venue
Journal of Cancer Research and Clinical Oncology
Publisher
Springer Science and Business Media LLC
Published
2023-08-31
Volume
149
Issue
17
Pages
16157-16177
ISSN
  • 0171-5216
  • 1432-1335
DOI
10.1007/s00432-023-05331-8
Cited by
13
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis. https://app.cochat.ai/papers/10.1007/s00432-023-05331-8
The paper
Sharma, S., Bhattacharya, S., Joshi, K., & Singh, S. (2023). A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-05331-8